AANMA has enjoyed a long history of bipartisan support from Congress to change laws affecting schoolchildren with asthma and anaphylaxis. We’ve worked with federal agencies such as FDA, EPA, CDC, NHLBI and NIAID to ensure evidence-based, cost-effective and patient-centered care. This collaborative effort means that today, it is possible to improve patient quality of life, prevent asthma and anaphylaxis deaths and suffering while reducing healthcare costs.
Read AANMA’s letter presenting our opposing views of the Asthma Inhaler Relief Act of 2012.
Read associations’ letter presenting opposing views of the Asthma Inhaler Relief Act of 2012.
Contact your representative and let them know about this important issue TODAY! Find contact info for your representative at: http://www.house.gov/representatives/find.